Prices delayed by at least 15 minutes | Print


Medtronic plc (MDT)

Common Stock
Sell: $80.7|Buy: $82|Change: 0.72 (0.89%)

Open 

$80.96


Previous close 

$80.57


Trade high 

$81.34


Volume 

5,296,230


Year high 

$92.02


Year low 

$68.84


Dividend yield 

3.43%


Market capitalisation 

$107.94 bn


P/E ratio 

25.58


ISIN 

IE00BTN1Y115


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date20/12/202322/03/2024
Ex-dividend date19/12/202321/03/2024
Payment date12/01/202412/04/2024
Amount$0.69$0.69

Performance 23/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Medtronic plc+ 0.89
More...

Company profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.